Despite significant progress in combating malaria in recent years the burden of severe
disease and death due to Plasmodium infections remains a global public health concern …

Populations exposed to Plasmodium infection develop genetic mechanisms of protection
against severe disease. The clinical manifestation of malaria results primarily from the lysis …

Background Plasmodium vivax malaria clinical outcomes are a consequence of the
interaction of multiple parasite, environmental and host factors. The host molecular and …

AIM To investigate the association between 16 insertion-deletions (INDEL) polymorphisms,
colorectal cancer (CRC) risk and clinical features in an admixed population. METHODS One …

Preeclampsia (PE) is a pregnancy‐specific disorder that results in maternal mortality and
morbidity. Growing evidence indicated that cytokines are involved in the pathogenesis of PE …

Abstract Objective Interleukin-4 (IL-4) is a strong chondroprotective cytokine and
polymorphisms within this gene may be a risk factor for osteoarthritis (OA). We aimed to …

Cerebral malaria (CM) is a neurological complication of infection with Plasmodium
falciparum that is partly caused by cytokine-mediated inflammation. It is not known whether …

In Volume 1 of “Dynamic Models of Infectious Diseases,” ISBN 978-1-4614-3960-8 and 978-
1-4614-3961-5 (eBook), we assembled eight chapters from highly acclaimed international …

Malaria is a life-threatening blood disease caused by the protozoan Plasmodium. Infection
may lead to several different patterns of symptoms in the host: asymptomatic state …

Bacteremia and malaria coinfection is a common and life‐threatening condition in children
residing in sub‐Saharan Africa. We previously showed that coinfection with Gram negative …